J. Safra Sarasin Holding’s Xenon Pharmaceuticals XENE Stock Holding History

J. Safra Sarasin Holding’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$527K	Sell	9,071 -4,510	-33%	-$208K	0.01%	400
2025 Q4	$609K	Sell	13,581 -16,587	-55%	-$697K	0.01%	379
2025 Q3	$1.21M	Sell	30,168 -51,880	-63%	-$1.83M	0.02%	290
2025 Q2	$2.57M	Buy	82,048 +51,475	+168%	+$1.68M	0.04%	183
2025 Q1	$1.03M	Buy	30,573 +12,787	+72%	+$486K	0.02%	320
2024 Q4	$697K	Buy	+17,786	New	+$735K	0.01%	378

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

J. Safra Sarasin Holding's XENE Position: Q1 2026 in Review

J. Safra Sarasin Holding reduced its Xenon Pharmaceuticals (XENE) stake by 33% in Q1 2026, selling an estimated $208K and leaving 9,071 shares worth $527K. The position accounts for 0.01% of the portfolio, ranked #400.

J. Safra Sarasin Holding first reported a position in XENE in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.57M in Q2 2025. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

J. Safra Sarasin Holding held 9,071 shares of Xenon Pharmaceuticals worth $527K as of Q1 2026.
J. Safra Sarasin Holding sold 4,510 Xenon Pharmaceuticals shares in Q1 2026, an estimated $208K.
Xenon Pharmaceuticals made up 0.01% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #400 holding.
J. Safra Sarasin Holding first reported a position in Xenon Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
J. Safra Sarasin Holding's Xenon Pharmaceuticals position peaked at $2.57M in Q2 2025.
290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.